Copy cats
The cloning of animals by somatic cell nuclear transfer has been carried out successfully for many years, however, the survival rates of cloned animals is very low. This has been attributed to abnormal gene expression in cloned placentas that results in the loss of the foetus or the death of newly born animals.
The cloning of animals by somatic cell nuclear transfer has been carried out successfully for many years, however, the survival rates of cloned animals is very low. This has been attributed to abnormal gene expression in cloned placentas that results in the loss of the foetus or the death of newly born animals.
A team of scientists in Korea have undertaken a study of the placentas of cloned cats to establish the changes that are occurring as a result of cloning.1 A proteomics analysis was performed in domestic cats to compare cloned term placentas (CTP) obtained from caesarean section (CS) to control placentas obtained from CS or vaginal delivery. The expression of 20 proteins was altered in CTP (p
The team concluded that these results were indicative that impaired cloning in cats was a direct result of abnormal protein production in the placentas. A strategy to restore normal protein expression could increase the efficiency of somatic cell nuclear transfer and, in time, help to establish endangered species.
1. Il-Keun Kong et al., Proteomics, 11(23), 4454–4467 (2011).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
